-
Grading Resected Invasive Squamous Cell Carcinoma of the Lung: A Practical, Globally Validated Approach Based on Tumor Budding
Drs. Mari Mino-Kenudson and Sabina Berezowska suggest that a standardized two-tier grading system presents an important step toward harmonizing LUSC grading worldwide.
More Recent News
-
What Do Recent ODAC Decisions Mean for Lung Cancer Drug Development and Clinical Trial Design?
In a Q&A with ILCN, Dr. John V. Heymach addresses several rulings from the Oncologic Drugs Advisory Committee and important lessons for research teams.
-
Investigational KRAS G12D Agents Demonstrate Promising Antitumor Activity in Non-Small Cell Lung Cancer
Early findings from two clinical studies support the continued development of setidegrasib and zoldonrasib to target KRAS G12D mutations.